View in EDS HTML Full Text PDF Full Text

ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.

Saved in:
Bibliographic Details
Title: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.
Authors: Schifanella L; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Barnett SW; Novartis Vaccines and Diagnostics, Inc, Cambridge, Massachusetts, United States of America., Bissa M; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Galli V; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Doster MN; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Vaccari M; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Tomaras GD; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America., Shen X; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America., Phogat S; Sanofi Pasteur, Swiftwater, Pennsylvania, United States of America., Pal R; Advanced BioScience Laboratories, Inc., Rockville, Maryland, United States of America., Montefiori DC; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America., LaBranche CC; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America., Rao M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America., Trinh HV; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; U.S. Military HIV Research Program, Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America., Washington-Parks R; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Liyanage NPM; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Gorini G, Brown DR; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America., Liang F; Karolinska Institute, Stockholm, Sweden., Loré K; Karolinska Institute, Stockholm, Sweden., Venzon DJ; Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Magnanelli W; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America., Metrinko M; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America., Kramer J; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America., Breed M; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America., Alter G; Ragon Institute of MGH, MIT, and Harvard Cambridge, Boston, Massachusetts, United States of America., Ruprecht RM; Texas Biomedical Research Institute, San Antonio, Texas, United States of America., Franchini G; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.
Source: PLoS pathogens [PLoS Pathog] 2019 Dec 03; Vol. 15 (12), pp. e1008121. Date of Electronic Publication: 2019 Dec 03 (Print Publication: 2019).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31794588
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schifanella+L%22">Schifanella L</searchLink>; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Barnett+SW%22">Barnett SW</searchLink>; Novartis Vaccines and Diagnostics, Inc, Cambridge, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Bissa+M%22">Bissa M</searchLink>; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Galli+V%22">Galli V</searchLink>; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Doster+MN%22">Doster MN</searchLink>; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Vaccari+M%22">Vaccari M</searchLink>; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Tomaras+GD%22">Tomaras GD</searchLink>; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Shen+X%22">Shen X</searchLink>; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Phogat+S%22">Phogat S</searchLink>; Sanofi Pasteur, Swiftwater, Pennsylvania, United States of America.<br /><searchLink fieldCode="AU" term="%22Pal+R%22">Pal R</searchLink>; Advanced BioScience Laboratories, Inc., Rockville, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Montefiori+DC%22">Montefiori DC</searchLink>; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22LaBranche+CC%22">LaBranche CC</searchLink>; Duke Human Vaccine Institute, Duke University, Durham, North Carolina, United States of America.<br /><searchLink fieldCode="AU" term="%22Rao+M%22">Rao M</searchLink>; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Trinh+HV%22">Trinh HV</searchLink>; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.; U.S. Military HIV Research Program, Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Washington-Parks+R%22">Washington-Parks R</searchLink>; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Liyanage+NPM%22">Liyanage NPM</searchLink>; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Gorini+G%22">Gorini G</searchLink><br /><searchLink fieldCode="AU" term="%22Brown+DR%22">Brown DR</searchLink>; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Liang+F%22">Liang F</searchLink>; Karolinska Institute, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Loré+K%22">Loré K</searchLink>; Karolinska Institute, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Venzon+DJ%22">Venzon DJ</searchLink>; Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Magnanelli+W%22">Magnanelli W</searchLink>; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Metrinko+M%22">Metrinko M</searchLink>; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Kramer+J%22">Kramer J</searchLink>; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Breed+M%22">Breed M</searchLink>; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America.<br /><searchLink fieldCode="AU" term="%22Alter+G%22">Alter G</searchLink>; Ragon Institute of MGH, MIT, and Harvard Cambridge, Boston, Massachusetts, United States of America.<br /><searchLink fieldCode="AU" term="%22Ruprecht+RM%22">Ruprecht RM</searchLink>; Texas Biomedical Research Institute, San Antonio, Texas, United States of America.<br /><searchLink fieldCode="AU" term="%22Franchini+G%22">Franchini G</searchLink>; Animal Models and Retroviral Vaccines Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101238921%22">PLoS pathogens</searchLink> [PLoS Pathog] 2019 Dec 03; Vol. 15 (12), pp. e1008121. <i>Date of Electronic Publication: </i>2019 Dec 03 (<i>Print Publication: </i>2019).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Public+Library+of+Science%22">Public Library of Science </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101238921 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1553-7374 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215537366%22">15537366 </searchLink><i>NLM ISO Abbreviation: </i>PLoS Pathog <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31794588
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1371/journal.ppat.1008121
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e1008121
    Titles:
      – TitleFull: ALVAC-HIV B/C candidate HIV vaccine efficacy dependent on neutralization profile of challenge virus and adjuvant dose and type.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schifanella L
      – PersonEntity:
          Name:
            NameFull: Barnett SW
      – PersonEntity:
          Name:
            NameFull: Bissa M
      – PersonEntity:
          Name:
            NameFull: Galli V
      – PersonEntity:
          Name:
            NameFull: Doster MN
      – PersonEntity:
          Name:
            NameFull: Vaccari M
      – PersonEntity:
          Name:
            NameFull: Tomaras GD
      – PersonEntity:
          Name:
            NameFull: Shen X
      – PersonEntity:
          Name:
            NameFull: Phogat S
      – PersonEntity:
          Name:
            NameFull: Pal R
      – PersonEntity:
          Name:
            NameFull: Montefiori DC
      – PersonEntity:
          Name:
            NameFull: LaBranche CC
      – PersonEntity:
          Name:
            NameFull: Rao M
      – PersonEntity:
          Name:
            NameFull: Trinh HV
      – PersonEntity:
          Name:
            NameFull: Washington-Parks R
      – PersonEntity:
          Name:
            NameFull: Liyanage NPM
      – PersonEntity:
          Name:
            NameFull: Gorini G
      – PersonEntity:
          Name:
            NameFull: Brown DR
      – PersonEntity:
          Name:
            NameFull: Liang F
      – PersonEntity:
          Name:
            NameFull: Loré K
      – PersonEntity:
          Name:
            NameFull: Venzon DJ
      – PersonEntity:
          Name:
            NameFull: Magnanelli W
      – PersonEntity:
          Name:
            NameFull: Metrinko M
      – PersonEntity:
          Name:
            NameFull: Kramer J
      – PersonEntity:
          Name:
            NameFull: Breed M
      – PersonEntity:
          Name:
            NameFull: Alter G
      – PersonEntity:
          Name:
            NameFull: Ruprecht RM
      – PersonEntity:
          Name:
            NameFull: Franchini G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 12
              Text: 2019 Dec 03
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1553-7374
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: PLoS pathogens
              Type: main
ResultId 1